CSIMarket Company Name, Ticker, Suppliers, else..
 
Si bone inc   (NASDAQ: SIBN)
 
Price: $18.3350 $0.03 0.191%
Day's High: $19.15999984741211 Week Perf: -0.89 %
Day's Low: $ 18.21 30 Day Perf: -3.5 %
Volume (M): 185,506 52 Wk High: $ 21.89
Volume (M$): $ 0 52 Wk Avg: $16.22
Open: $18.65 52 Wk Low: $11.48



 Market Capitalization (Millions $) 815
 Shares Outstanding (Millions) 44
 Employees 376
 Revenues (TTM) (Millions $) 214
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 7

Business Description


Si-Bone Inc. is a medical device company that focuses on the development and distribution of minimally invasive surgical devices for the treatment of musculoskeletal disorders. The company was founded in 2008 and is based in Santa Clara, California.

One of Si-Bone's most groundbreaking products is the iFuse Implant System, which is used to treat sacroiliac joint dysfunction. This condition is often caused by damage or degeneration to the sacroiliac joint, which can result in severe lower back pain and negatively impact a patient's quality of life.

The iFuse Implant System consists of a set of triangular shaped implants that are surgically placed across the sacroiliac joint, providing support to the affected area while promoting fusion of the joint. This technology has been proven effective in numerous clinical studies and has been used in thousands of surgical procedures.

In addition to their flagship product, Si-Bone also offers a range of other surgical devices for the treatment of musculoskeletal conditions. These include the iFuse-3D Implant System, which uses three-dimensional printing technology to create custom implants for patients, and the iFuse-CG Implant System, which provides additional compression and stability to the sacroiliac joint.

Si-Bone is known for its commitment to innovation, with a team of talented engineers and researchers constantly working to develop and improve their surgical technologies. The company has also established strong partnerships with leading medical institutions, including the Mayo Clinic and Harvard Medical School.

Si-Bone's products have been widely adopted by healthcare professionals, and the company has received numerous industry accolades for its innovative technologies. They continue to expand their presence in the medical device industry, with a focus on improving patient outcomes and providing minimally invasive solutions for a wide range of musculoskeletal conditions.


   Company Address: 471 El Camino Real Santa Clara 95050 CA
   Company Phone Number: 207-0700   Stock Exchange / Ticker: NASDAQ SIBN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ENOV   -4.41%    
EW   -5.11%    
GMED   -5.84%    
MDT   -2.35%    
SYK   -12.49%    
TFX   -7.75%    
• View Complete Report
   



Product Service News

The iFuse Bedrock Granite System Navigating Challenges and Opportunities in the Changing Landscape of Medical Device ...

Published Tue, Nov 5 2024 1:30 PM UTC

In the competitive landscape of medical devices, companies are continually grappling with regulatory hurdles and market dynamics that can significantly impact their growth trajectories. Among those navigating this challenging terrain is SI-BONE, a company specializing in surgical implants for the treatment of the sacroiliac joint and other orthopedic applications. Recently, ...
Product Service News

Revamping Pelvic Fracture Treatment SI-BONEs Breakthrough Device Marks a New Era in Surgical Solutions

Published Thu, Oct 10 2024 12:30 PM UTC

In a groundbreaking development for the medical device industry and the treatment of pelvic fractures, SI-BONE, Inc. a leading innovator in surgical solutions for sacropelvic disorders, has successfully completed the first-in-patient procedures utilizing its FDA-designated breakthrough device, the iFuse TORQ TNT Implant System. Announced on October 10, 2024, the significant ...
Management Announcement

SI-BONE, Inc. Receives FDA Clearance and Breakthrough Status for Revolutionary Pelvic Fracture Fixation System

Published Tue, Aug 20 2024 12:30 PM UTC



SANTA CLARA, Calif., Aug. 20, 2024 - SI-BONE, Inc. (Nasdaq: SIBN), a leading medical device company specializing in surgical solutions for sacropelvic disorders, has recently obtained FDA 510(k) clearance for its innovative iFuse TORQ TNT Implant System (TNT). This breakthrough technology is specifically designed to address the anatomical and bone mineral density ...
Product Service News

SI-BONE, Inc. Revolutionizes Sacropelvic Treatment with New Granite Implant System, Accomplishes Substantial Revenue Growth

Published Tue, Jan 30 2024 1:30 PM UTC

SI-BONE, Inc., a leading medical device company focusing on musculoskeletal disorders of the sacropelvic anatomy, has recently received FDA 510(k) clearance for its improved iFuse Bedrock Granite Implant System. This new system features a smaller 9.5 mm diameter, making it more versatile for use in various anatomical conditions. Additionally, the clearance now includes an ex...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 3.80
Price to Sales (Expected) -
Price to Book 4.47
PEG (TTM) -

Financial Strength Current
Quick Ratio 5.89
Working Capital Ratio 9.15
Leverage Ratio (MRQ) 0.36
Total Debt to Equity 0.2
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.34 $
Revenues (TTM) 4.82 $
Cash Flow (TTM) -
Cash 3.18 $
Book Value 4.1 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 570,029
Net Income per Employee (TTM) -38,915
Receivable Turnover Ratio (TTM) 7.23
Inventory Turnover Ratio (TTM) 1.24
Asset Turnover Ratio (TTM) 0.87

Profitability Ratios Current
Gross Margin (MRQ) 79.54 %
Operating Margin (MRQ) -8.58 %
Net Margin (MRQ) -7.3 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Si Bone Inc's Segments
United States    183.07 % of total Revenue
Non-US    10.82 % of total Revenue

  Si Bone Inc Outlook

On February 24 2025 the Si Bone Inc provided following guidance

nnSI-BONE, Inc. Announces Exceptional Financial Performance for Q4 2024 and Provides Forward-Looking Guidance for 2025nn

SI-BONE, Inc. has reported remarkable financial achievements for the fourth quarter of 2024, showcasing a substantial 26% increase in global revenue year-over-year alongside a positive adjusted EBITDA. This impressive growth underscores the company's effective strategies and robust market position.

While the company has shared its outlook for 2025, specific details regarding the financial guidance remain undisclosed. Investors and s alike will be keenly awaiting further elaboration on projected figures and financial metrics as the year progresses.

The fourth quar...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.